重大事件
即時報告
8-K
2026-05-29
Moleculin Biotech提交8-K 附附件99.1 披露潛在重大信息
AI 繁中摘要
Moleculin Biotech, Inc.（股票代號：MBRX）於2026年5月29日向美國證監會提交8-K表格，觸發項目包括第7.01項（Regulation FD披露）及第9.01項（財務報表及展品）。是次申報主要附有一份附件99.1（展品），但該8-K本身並未包含具體財務數字或管理層展望。投資者應直接查閱附件99.1的內容，以了解公司透過FD渠道發布的潛在重大信息（例如臨床試驗更新、業務合作或資本市場活動）。由於Moleculin Biotech屬於生物製藥行業，任何研發里程碑或監管消息均可能對股價帶來波動，建議密切留意後續公告。
展開英文正文
EDGAR Filing Documents for 0001437749-26-018819 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001437749-26-018819 Filing Date 2026-05-29 Accepted 2026-05-29 09:26:14 Documents 14 Period of Report 2026-05-29 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K mbrx20260529_8k.htm iXBRL 8-K 26229 2 EXHIBIT 99.1 ex_969652.htm EX-99.1 21438 7 logobig.jpg GRAPHIC 19220 Complete submission text file 0001437749-26-018819.txt 240228 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20260529.xsd EX-101.SCH 3580 4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20260529_def.xml EX-101.DEF 11808 5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20260529_lab.xml EX-101.LAB 15859 6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20260529_pre.xml EX-101.PRE 12023 17 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20260529_8k_htm.xml XML 2946 Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160 Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings) EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 261039511 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)